The latest EU/EEA figures show a continuing upward trend in the number of cases of dengue imported from dengue-endemic regions, as well as an increasing number of local outbreaks of West Nile virus infections and dengue within the EU/EEA.
From 3–7 June 2024, the Institute of Public Health of Serbia "Dr. Milan Jovanovic Batut" hosted an intensive training module on One Health approaches to field epidemiology practice in MediPIET countries.
The European Centre for Disease Prevention and Control (ECDC) has published a report today highlighting the threat of increasing antimicrobial resistance (AMR) in Neisseria gonorrhoeae.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
Due to the concerning rise in sexually transmitted infection (STIs) transmission across Europe, the European Centre for Disease Prevention and Control (ECDC) is urging everyone to keep informed and practice safer sex as they leave for holidays, festivals, and travel this summer season.
On 31 May 2024, the European Medicines Agency (EMA) published the Committee for Medicinal Products for Human Use (CHMP) reflection paper on Creutzfeldt-Jakob disease (CJD) and plasma-derived and urine-derived medicinal products.
ECDC is monitoring reports from three countries (France, the United Kingdom and the United States) of cases of invasive meningococcal disease (IMD) associated with travel to the Kingdom of Saudi Arabia (KSA).
In a concerted effort to combat healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), the European Centre for Disease Prevention and Control (ECDC) and the Belgian EU Presidency on 6-7 May co-hosted a conference at the national public health institute of Belgium, Sciensano, in Brussels.
In connection with the European Immunization Week, ECDC releases data indicating an increase in cases of vaccine-preventable diseases such as measles and pertussis, after decreased levels during the COVID-19 pandemic.
A cross-border outbreak of Salmonella Mbandaka ST413 has been ongoing in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) for over two years since September 2021, as detailed in an updated joint Rapid Outbreak Assessment by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).